Stand Up To Cancer awards Dr. Irene Ghobrial $10M to develop blood-based cancer test — 4 insights

Stand Up To Cancer awarded Boston-based Dana Farber Cancer Institute’s Irene Ghobrial, MD, $10 million to lead a group of U.S. scientists in developing a blood-based cancer test, WCVB reports.

Advertisement

Here’s what you should know:

1. Researchers are conducting a study of the blood-based test over the next two years.

2. They plan to enroll up to 50,000 people. They’re looking for African-Americans over 45 years old or 45-year-old individuals with a first-degree relative diagnosed with myeloma.

3. Researchers expect about 3,000 patients to test positive.

4. Dr. Ghobrial said, “They will get their blood drawn and we tell them whether they do indeed have a positive test or not and then we guide them through the steps of what to do after that.”

More articles on improving performance:
The Joint Commission releases 4 ambulatory healthcare national patient safety goals for 2019
Going on the ‘cyberoffensive’: Tom Hui shares the 2 steps to take after a cybersecurity breach
Will Amazon shake up the ASC supply chain? Here’s what 4 experts say

Advertisement

Next Up in ASC News

  • ASCs have taken center stage of many hospital and health systems’ growth and development strategies in recent years as they…

  • Germantown, Md.-based Capital Surgical Solutions plans to open a new ASC in Portland, Ore., in the fourth quarter of 2026,…

Advertisement

Comments are closed.